1. Home
  2. RYDE vs LYRA Comparison

RYDE vs LYRA Comparison

Compare RYDE & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYDE
  • LYRA
  • Stock Information
  • Founded
  • RYDE 2014
  • LYRA 2005
  • Country
  • RYDE Singapore
  • LYRA United States
  • Employees
  • RYDE N/A
  • LYRA N/A
  • Industry
  • RYDE
  • LYRA Medical/Dental Instruments
  • Sector
  • RYDE
  • LYRA Health Care
  • Exchange
  • RYDE NYSE
  • LYRA Nasdaq
  • Market Cap
  • RYDE 13.0M
  • LYRA 13.5M
  • IPO Year
  • RYDE 2024
  • LYRA 2020
  • Fundamental
  • Price
  • RYDE $0.50
  • LYRA $0.19
  • Analyst Decision
  • RYDE Strong Buy
  • LYRA Buy
  • Analyst Count
  • RYDE 1
  • LYRA 5
  • Target Price
  • RYDE $9.00
  • LYRA $4.50
  • AVG Volume (30 Days)
  • RYDE 1.9M
  • LYRA 1.7M
  • Earning Date
  • RYDE 10-23-2024
  • LYRA 03-20-2025
  • Dividend Yield
  • RYDE N/A
  • LYRA N/A
  • EPS Growth
  • RYDE N/A
  • LYRA N/A
  • EPS
  • RYDE N/A
  • LYRA N/A
  • Revenue
  • RYDE $5,761,982.00
  • LYRA $1,471,000.00
  • Revenue This Year
  • RYDE $2.61
  • LYRA N/A
  • Revenue Next Year
  • RYDE $21.90
  • LYRA N/A
  • P/E Ratio
  • RYDE N/A
  • LYRA N/A
  • Revenue Growth
  • RYDE N/A
  • LYRA 3.37
  • 52 Week Low
  • RYDE $0.28
  • LYRA $0.16
  • 52 Week High
  • RYDE $22.49
  • LYRA $6.79
  • Technical
  • Relative Strength Index (RSI)
  • RYDE N/A
  • LYRA 47.25
  • Support Level
  • RYDE N/A
  • LYRA $0.18
  • Resistance Level
  • RYDE N/A
  • LYRA $0.20
  • Average True Range (ATR)
  • RYDE 0.00
  • LYRA 0.02
  • MACD
  • RYDE 0.00
  • LYRA -0.00
  • Stochastic Oscillator
  • RYDE 0.00
  • LYRA 22.11

About RYDE RYDE GROUP LTD

Ryde Group Ltd is a company providing a super mobility app offering ultimate convenience and reliability for their customers through multiple mobility tools that can be accessed and function seamlessly out of a single app. The company operates in the following segments such as being mobility where it provides on-demand and scheduled carpooling and ride-hailing services, matching riders to driver partners; and quick commerce where it provides on-demand, scheduled, and multi-stop parcel delivery services.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: